Live Breaking News & Updates on Exem Foam Inc

Stay updated with breaking news from Exem foam inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ExEm® Foam, the only FDA-approved contrast agent for ultrasound tubal patency testing, now available in the U.S.


Share this article
Share this article
NASHVILLE, Tenn., Feb. 17, 2021 /PRNewswire/ ExEm® Foam Inc announced today that ExEm® Foam ((air polymer-type A) intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics nationwide. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm® Foam to assess whether there may be a blockage in the fallopian tubes in women with known or suspected infertility. The innovative imaging technique offers a less complicated and less invasive alternative to laparoscopy and dye, the gold standard for diagnosing tubal patency. The outpatient tubal assessment is also associated with significantly lower pain scores as compared to the standard of care, X-ray hysterosalpingography (HSG), and does not require the use of radiation and iodine. ....

Zuid Holland , Johan Remmerswaal , Mark Hans Emanuel , Jack Shanagher , University Medical Center Utrecht , Women Health , Drug Administration , Department Gynecology , Foam Inc , Exem Foam Inc , Professor Mark Hans Emanuel , Reproductive Medicine , Exem Foam , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment , New Products Amp Services , குறி ஹான்ஸ் இமானுவேல் , பல்கலைக்கழகம் மருத்துவ மையம் அட்ரெக்ட் , பெண்கள் ஆரோக்கியம் , துறை பெண்ணோயியல் , நுரை இன்க் , ப்ரொஃபெஸர் குறி ஹான்ஸ் இமானுவேல் , இனப்பெருக்கம் மருந்து , ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் , மருத்துவ மருந்துகள் ,